Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial

BACKGROUND: Women with BRCA1/2 mutations have a higher risk of developing breast and ovarian cancer compared to women of the general population. Various preventive options are available to deal with the increased risk of developing cancer. These include intensified breast cancer screening and risk-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kautz-Freimuth, Sibylle, Redaèlli, Marcus, Isselhard, Anna, Shukri, Arim, Vodermaier, Andrea, Rhiem, Kerstin, Schmutzler, Rita, Stock, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848811/
https://www.ncbi.nlm.nih.gov/pubmed/35172875
http://dx.doi.org/10.1186/s13063-022-06081-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848811/
https://www.ncbi.nlm.nih.gov/pubmed/35172875
http://dx.doi.org/10.1186/s13063-022-06081-7

Ejemplares similares